TransMedics Group (NASDAQ: TMDX) revenue
TransMedics Group reported revenue of $605.5m for fiscal 2025, 37.1% more than in fiscal 2024 ($441.5m). Since fiscal 2018 its revenue has grown by 4,031.1%, an average growth of 70.2% a year.
TransMedics Group has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 8 fiscal years on record. The biggest drop was in fiscal 2020, −0.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $605.5m | +37.1% | $108.6m | 17.9% |
| 2024 | $441.5m | +82.7% | $37.5m | 8.5% |
| 2023 | $241.6m | +158.5% | −$28.7m | −11.9% |
| 2022 | $93.5m | +208.8% | −$31.4m | −33.6% |
| 2021 | $30.3m | +18.0% | −$39.4m | −130.3% |
| 2020 | $25.6m | −0.8% | −$26.4m | −102.9% |
| 2019 | $25.8m | +76.3% | −$29.6m | −114.5% |
| 2018 | $14.7m | — | −$20.2m | −138.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
TransMedics Group revenue compared with its sector
By revenue for its latest fiscal year, TransMedics Group ranks 184th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; TransMedics Group, 37.1%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 182nd | OPKO Health | $606.9m | −14.9% |
| 183rd | Insmed | $606.4m | 66.7% |
| 184th | TransMedics Group | $605.5m | 37.1% |
| 185th | UFP Technologies | $602.8m | 19.5% |
| 186th | Azenta | $593.8m | 3.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of TransMedics Group
- How much revenue did TransMedics Group make in fiscal 2025?
- TransMedics Group reported revenue of $605.5m for fiscal 2025, compared with $441.5m in fiscal 2024.
- How much has the revenue of TransMedics Group grown?
- Between fiscal 2018 and fiscal 2025 it went from $14.7m to $605.5m: 4,031.1% more, an average growth of 70.2% a year.
- What was the best year for revenue at TransMedics Group?
- Of its last 8 fiscal years, fiscal 2025, with $605.5m.
- Where does TransMedics Group rank in its sector by revenue?
- It ranks 184th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for TransMedics Group come from?
- From the annual report (Form 10-K) that TransMedics Group files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that TransMedics Group files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on TransMedics Group: the TransMedics Group page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.